甲状腺切除术后瘢痕管理中A型肉毒毒素早期注射时机的分侧对照研究
本研究纳入甲状腺切除术成人患者,手术当天在一侧切口周围注射A型肉毒毒素,2周后在另一侧以相同剂量和方式注射,于术后2、4、12、24周进行瘢痕评估。结果显示手术当天注射侧在客观瘢痕评价和患者满意度上优于术后2周注射侧,差异自术后第4周起显著,术后24周红斑指数和皮肤弹性显著改善。
要点
- 手术当天注射BTxA侧在术后24周客观瘢痕评价和患者满意度上优于术后2周注射侧。
- 两侧差异自术后第4周起显著,术后24周红斑指数和皮肤弹性显著改善。
核心结论
- 术后立即注射A型肉毒毒素在红斑、皮肤弹性和患者满意度方面对甲状腺切除术瘢痕管理更有效。
研究设计与样本
- 分侧瘢痕自身对照研究,纳入接受甲状腺切除术的成人患者,手术当天在一侧切口周围注射BTxA,2周后在另一侧以相同剂量和方式注射。
主要发现
- 术后24周客观瘢痕评价和患者满意度显示手术当天注射侧优于术后2周注射侧,差异自术后第4周起显著。
- 术后24周最终定量瘢痕评估显示红斑指数和皮肤弹性显著改善。
关键数值与推荐
- 评估工具包括改良Stony Brook瘢痕评价量表、视觉模拟量表和红斑指数,于术后2、4、12、24周进行评价。
- 术后24周定量评估红斑指数、皮肤弹性、黑色素指数和摩擦度。
临床怎么用
- 甲状腺切除术后可考虑在手术当天即刻进行切口周围BTxA注射以优化瘢痕管理。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Botulinum toxin type A (BTxA) injection is effective for surgical scar prevention. Although some studies have aimed to confirm the efficacy of BTxA injection at different time points, none has been conducted to determine the most appropriate timing of injection for scar management. The authors predicted that the injection of BTxA at different times during the wound healing process would cause differing scar quality improvement and clarify unknown molecular mechanisms. METHODS: The study included adults who underwent thyroidectomy. All patients received paralesional BTxA injections on the day of the surgery on either the right or left side of the operative site. The same dose was injected on the noninjected side by means of the same method after 2 weeks. At 2, 4, 12, and 24 weeks postoperatively, the modified Stony Brook Scar Evaluation Scale, visual analogue scale, and erythema index were used for objective, subjective, and quantitative evaluations of the scar. At week 24 postoperatively, a quantitative scar assessment was performed with respect to the erythema index, skin elasticity, melanin index, and friction. RESULTS: On objective evaluation of the scar and patient satisfaction at 24 weeks postoperatively, the operation-day injection side showed better outcomes than the 2-week-postoperative injection side. These differences were significant from postoperative week 4. In the final quantitative scar assessment at postoperative week 24, significant improvements were observed in the erythema index and skin elasticity. CONCLUSION: These results suggest that immediate postoperative BTxA injection is more effective for thyroidectomy scar management in terms of erythema, skin elasticity, and patient satisfaction. CLINICAL QUESTION/LEVEL OF EVIDENCE: Therapeutic, II.
引用
- An MK, Cho EB, Park EJ, et al. Appropriate Timing of Early Postoperative Botulinum Toxin Type A Injection for Thyroidectomy Scar Management: A Split-Scar Study. Plast Reconstr Surg. 2019. PMID: 31568312. doi:10.1097/PRS.0000000000006064
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。